Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. With an overall survival rate of around 13%, it’s also one of the deadliest cancers. One reason for this is that ...

Add Yahoo as a preferred source to see more of our stories on Google. Spanish scientists say they have developed a potential breakthrough cure for treating pancreatic cancer, but the new therapy isn't ...

More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in the later stages. A medical expert is now warning about its further spread ...

Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

As women, we don't tend to give pancreatic cancer much thought. Instances of the disease are pretty rare overall, with pancreatic cancer only accounting for 3% of all cancers in the United States, per ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...